Waters Corporation (WAT) - Q1 2003 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2003. Waters Corporation is the world's largest manufacturer of high performance liquid chromatography (HPLC) instruments and a leader in mass spectrometry and thermal analysis. The company operates as a single reporting segment aggregating its Waters, Micromass, and TA Instruments divisions.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Net Sales | $220.999 million | $200.341 million |
| Gross Profit | $126.788 million | $115.707 million |
| Gross Margin | 57.4% | 57.8% |
| Operating Income | $42.844 million | $43.996 million |
| Net Income | $33.977 million | $30.544 million |
| Diluted EPS | $0.26 | $0.22 |
| Operating Cash Flow | $44.784 million | $50.454 million |
| Cash & Equivalents | $271.572 million | $250.761 million |
| Total Debt (Notes Payable) | $96.057 million | $2.665 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10% year-over-year, driven by a 2% organic increase and an 8% boost from favorable currency translation (stronger Euro and British Pound). Thermal analysis sales grew double-digits due to the Rheometrics acquisition.
- Debt Increase: Current debt surged from $2.7 million to $96.1 million. This increase is primarily due to borrowings under a $250 million credit facility used to fund the completion of a $200 million stock repurchase program.
- One-Time Charges: Operating income was impacted by a $5.0 million loss on the disposal of the inorganic mass spectrometry product line and $1.2 million in restructuring charges related to the integration of Micromass and HPLC operations.
- Acquisitions: The company acquired Rheometric Scientific's rheology business for approximately $17 million in cash and assumed liabilities, and acquired the remaining 30% of its Korean distributor for $2.4 million.
Guidance, Outlook, and Risks
- Outlook: Management expects gross profit margins to improve later in the year following the disposal of the inorganic mass spectrometry line and through manufacturing integration benefits. Capital expenditures are expected to remain consistent with ongoing quarterly needs.
- Stock Repurchase: The $200 million buyback program was completed in Q1. On May 6, 2003, the Board authorized a new program to repurchase up to $400 million of common stock over two years.
- Legal Contingencies:
- Applera Litigation: A U.S. District Court affirmed a jury verdict finding patent infringement. Waters paid approximately $53.7 million in damages and interest in April 2003. Similar claims exist in Japan and Canada with uncertain outcomes.
- Environmental: The company recorded an additional $1.2 million provision for an environmental matter at its Taunton facility, expecting settlement in Q2 2003.
- Hewlett-Packard Litigation: Ongoing patent disputes in Germany, France, and England regarding the "Alliance" pump. Provisions have been recorded for estimated damages.
- Accounting Changes: The company reclassified field service expenses to cost of sales and demo inventory to inventories to align with industry peers and ensure consistent classification.
Investor Verification Checklist
- Debt Utilization: Verify the terms and interest rates of the $94 million drawn against the credit facility and the impact on future interest expense.
- Litigation Exposure: Monitor the status of pending patent litigation in Japan and Canada regarding the Applera case, as outcomes could be material.
- Restructuring Progress: Track the execution of the Micromass/HPLC integration and the associated cost savings versus the $1.2 million charge taken in Q1.
- Stock Buyback Execution: Confirm the pace of the new $400 million share repurchase program authorized in May 2003.
- Environmental Settlement: Verify the final settlement amount for the Taunton facility environmental claim expected in Q2 2003.